aluates Reports

$ 0.0

Automative

Global Covid-19 Vaccine Market Research Report 2026

Published Date: 2026-02-27

Report Code: QYRE-Auto-27P8926

Global Covid 19 Vaccine Market Size Status and Forecast 2022

BUY CHAPTERS

Global Covid-19 Vaccine Market Research Report 2026

Code: QYRE-Auto-27P8926

Report

2026-02-27

Pages:103

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Moderna, Inc

CanSino Biologicals

Inovio Pharmaceuticals

Shenzhen Geno-Immune Medical Institute

GlaxoSmithKine

Pfizer Inc

Johnson & Johnson

Heat Biologics

Sanofi

Covid-19 Vaccine Market

The global Covid-19 Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

A COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID-19). Although no vaccine has completed clinical trials, there are multiple attempts in progress to develop such a vaccine.

The genetic sequence of SARS-CoV-2, the coronavirus that causes COVID-19, was published on 11 January 2020, triggering intense global R&D activity to develop a vaccine against the disease. The scale of the humanitarian and economic impact of the COVID-19 pandemic is driving evaluation of next-generation vaccine technology platforms through novel paradigms to accelerate development, and the first COVID-19 vaccine candidate entered human clinical testing with unprecedented rapidity on 16 March 2020.

The global vaccine R&D effort in response to the COVID-19 pandemic is unprecedented in terms of scale and speed. Given the imperative for speed, there is an indication that vaccine could be available under emergency use or similar protocols by early 2021. This would represent a fundamental step change from the traditional vaccine development pathway, which takes on average over 10 years, even compared with the accelerated 5-year timescale for development of the first Ebola vaccine, and will necessitate novel vaccine development paradigms involving parallel and adaptive development phases, innovative regulatory processes and scaling manufacturing capacity.

North America is the largest consumption place, with a consumption market share nearly 53.8% in 2026, Europe is the second largest consumption place with the consumption market share of 24.61% in 2026.

This report delivers a comprehensive overview of the global Covid-19 Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Covid-19 Vaccine. The Covid-19 Vaccine market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Covid-19 Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Covid-19 Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Covid-19 Vaccine Market Report

Report Metric	Details
Report Name	Covid-19 Vaccine Market
Segment by Type	DNA Non-replicating Viral Vector Protein Subunit RNA Others
Segment by Application	Adults Children
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, GlaxoSmithKine, Pfizer, Johnson＆Johnson, Heat Biologics, Sanofi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Covid-19 Vaccine companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Covid-19 Vaccine Market report?

Ans: The main players in the Covid-19 Vaccine Market are Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, GlaxoSmithKine, Pfizer, Johnson＆Johnson, Heat Biologics, Sanofi

What are the Application segmentation covered in the Covid-19 Vaccine Market report?

Ans: The Applications covered in the Covid-19 Vaccine Market report are Adults, Children

What are the Type segmentation covered in the Covid-19 Vaccine Market report?

Ans: The Types covered in the Covid-19 Vaccine Market report are DNA, Non-replicating Viral Vector, Protein Subunit, RNA, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Covid-19 Vaccine Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 DNA

1.2.3 Non-replicating Viral Vector

1.2.4 Protein Subunit

1.2.5 RNA

1.2.6 Others

1.3 Market by Application

1.3.1 Global Covid-19 Vaccine Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Adults

1.3.3 Children

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Covid-19 Vaccine Market Perspective (2021–2032)

2.2 Global Covid-19 Vaccine Growth Trends by Region

2.2.1 Global Covid-19 Vaccine Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Covid-19 Vaccine Historic Market Size by Region (2021–2026)

2.2.3 Covid-19 Vaccine Forecasted Market Size by Region (2027–2032)

2.3 Covid-19 Vaccine Market Dynamics

2.3.1 Covid-19 Vaccine Industry Trends

2.3.2 Covid-19 Vaccine Market Drivers

2.3.3 Covid-19 Vaccine Market Challenges

2.3.4 Covid-19 Vaccine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Covid-19 Vaccine Players by Revenue

3.1.1 Global Top Covid-19 Vaccine Players by Revenue (2021–2026)

3.1.2 Global Covid-19 Vaccine Revenue Market Share by Players (2021–2026)

3.2 Global Top Covid-19 Vaccine Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Covid-19 Vaccine Revenue

3.4 Global Covid-19 Vaccine Market Concentration Ratio

3.4.1 Global Covid-19 Vaccine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Vaccine Revenue in 2025

3.5 Global Key Players of Covid-19 Vaccine Head Offices and Areas Served

3.6 Global Key Players of Covid-19 Vaccine, Products and Applications

3.7 Global Key Players of Covid-19 Vaccine, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Covid-19 Vaccine Breakdown Data by Type

4.1 Global Covid-19 Vaccine Historic Market Size by Type (2021–2026)

4.2 Global Covid-19 Vaccine Forecasted Market Size by Type (2027–2032)

5 Covid-19 Vaccine Breakdown Data by Application

5.1 Global Covid-19 Vaccine Historic Market Size by Application (2021–2026)

5.2 Global Covid-19 Vaccine Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Covid-19 Vaccine Market Size (2021–2032)

6.2 North America Covid-19 Vaccine Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Covid-19 Vaccine Market Size by Country (2021–2026)

6.4 North America Covid-19 Vaccine Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Covid-19 Vaccine Market Size (2021–2032)

7.2 Europe Covid-19 Vaccine Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Covid-19 Vaccine Market Size by Country (2021–2026)

7.4 Europe Covid-19 Vaccine Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Covid-19 Vaccine Market Size (2021–2032)

8.2 Asia-Pacific Covid-19 Vaccine Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Covid-19 Vaccine Market Size by Region (2021–2026)

8.4 Asia-Pacific Covid-19 Vaccine Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Covid-19 Vaccine Market Size (2021–2032)

9.2 Latin America Covid-19 Vaccine Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Covid-19 Vaccine Market Size by Country (2021–2026)

9.4 Latin America Covid-19 Vaccine Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Covid-19 Vaccine Market Size (2021–2032)

10.2 Middle East & Africa Covid-19 Vaccine Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Covid-19 Vaccine Market Size by Country (2021–2026)

10.4 Middle East & Africa Covid-19 Vaccine Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Moderna

11.1.1 Moderna Company Details

11.1.2 Moderna Business Overview

11.1.3 Moderna Covid-19 Vaccine Introduction

11.1.4 Moderna Revenue in Covid-19 Vaccine Business (2021–2026)

11.1.5 Moderna Recent Development

11.2 CanSino Biologicals

11.2.1 CanSino Biologicals Company Details

11.2.2 CanSino Biologicals Business Overview

11.2.3 CanSino Biologicals Covid-19 Vaccine Introduction

11.2.4 CanSino Biologicals Revenue in Covid-19 Vaccine Business (2021–2026)

11.2.5 CanSino Biologicals Recent Development

11.3 Inovio Pharmaceuticals

11.3.1 Inovio Pharmaceuticals Company Details

11.3.2 Inovio Pharmaceuticals Business Overview

11.3.3 Inovio Pharmaceuticals Covid-19 Vaccine Introduction

11.3.4 Inovio Pharmaceuticals Revenue in Covid-19 Vaccine Business (2021–2026)

11.3.5 Inovio Pharmaceuticals Recent Development

11.4 Shenzhen Geno-Immune Medical Institute

11.4.1 Shenzhen Geno-Immune Medical Institute Company Details

11.4.2 Shenzhen Geno-Immune Medical Institute Business Overview

11.4.3 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Introduction

11.4.4 Shenzhen Geno-Immune Medical Institute Revenue in Covid-19 Vaccine Business (2021–2026)

11.4.5 Shenzhen Geno-Immune Medical Institute Recent Development

11.5 GlaxoSmithKine

11.5.1 GlaxoSmithKine Company Details

11.5.2 GlaxoSmithKine Business Overview

11.5.3 GlaxoSmithKine Covid-19 Vaccine Introduction

11.5.4 GlaxoSmithKine Revenue in Covid-19 Vaccine Business (2021–2026)

11.5.5 GlaxoSmithKine Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Details

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Covid-19 Vaccine Introduction

11.6.4 Pfizer Revenue in Covid-19 Vaccine Business (2021–2026)

11.6.5 Pfizer Recent Development

11.7 Johnson＆Johnson

11.7.1 Johnson＆Johnson Company Details

11.7.2 Johnson＆Johnson Business Overview

11.7.3 Johnson＆Johnson Covid-19 Vaccine Introduction

11.7.4 Johnson＆Johnson Revenue in Covid-19 Vaccine Business (2021–2026)

11.7.5 Johnson＆Johnson Recent Development

11.8 Heat Biologics

11.8.1 Heat Biologics Company Details

11.8.2 Heat Biologics Business Overview

11.8.3 Heat Biologics Covid-19 Vaccine Introduction

11.8.4 Heat Biologics Revenue in Covid-19 Vaccine Business (2021–2026)

11.8.5 Heat Biologics Recent Development

11.9 Sanofi

11.9.1 Sanofi Company Details

11.9.2 Sanofi Business Overview

11.9.3 Sanofi Covid-19 Vaccine Introduction

11.9.4 Sanofi Revenue in Covid-19 Vaccine Business (2021–2026)

11.9.5 Sanofi Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Moderna, Inc

CanSino Biologicals

Inovio Pharmaceuticals

Shenzhen Geno-Immune Medical Institute

GlaxoSmithKine

Pfizer Inc

Johnson & Johnson

Heat Biologics

Sanofi

List of Tables

Table 1. Global Covid-19 Vaccine Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of DNA

Table 3. Key Players of Non-replicating Viral Vector

Table 4. Key Players of Protein Subunit

Table 5. Key Players of RNA

Table 6. Key Players of Others

Table 7. Global Covid-19 Vaccine Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Covid-19 Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 9. Global Covid-19 Vaccine Market Size by Region (US$ Million), 2021–2026

Table 10. Global Covid-19 Vaccine Market Share by Region (2021–2026)

Table 11. Global Covid-19 Vaccine Forecasted Market Size by Region (US$ Million), 2027–2032

Table 12. Global Covid-19 Vaccine Market Share by Region (2027–2032)

Table 13. Covid-19 Vaccine Market Trends

Table 14. Covid-19 Vaccine Market Drivers

Table 15. Covid-19 Vaccine Market Challenges

Table 16. Covid-19 Vaccine Market Restraints

Table 17. Global Covid-19 Vaccine Revenue by Players (US$ Million), 2021–2026

Table 18. Global Covid-19 Vaccine Market Share by Players (2021–2026)

Table 19. Global Top Covid-19 Vaccine Players by Tier (Tier 1, Tier 2, and Tier 3), based on Covid-19 Vaccine Revenue, 2025

Table 20. Ranking of Global Top Covid-19 Vaccine Companies by Revenue (US$ Million) in 2025

Table 21. Global 5 Largest Players Market Share by Covid-19 Vaccine Revenue (CR5 and HHI), 2021–2026

Table 22. Global Key Players of Covid-19 Vaccine, Headquarters and Area Served

Table 23. Global Key Players of Covid-19 Vaccine, Products and Applications

Table 24. Global Key Players of Covid-19 Vaccine, Date of General Availability (GA)

Table 25. Mergers and Acquisitions, Expansion Plans

Table 26. Global Covid-19 Vaccine Market Size by Type (US$ Million), 2021–2026

Table 27. Global Covid-19 Vaccine Revenue Market Share by Type (2021–2026)

Table 28. Global Covid-19 Vaccine Forecasted Market Size by Type (US$ Million), 2027–2032

Table 29. Global Covid-19 Vaccine Revenue Market Share by Type (2027–2032)

Table 30. Global Covid-19 Vaccine Market Size by Application (US$ Million), 2021–2026

Table 31. Global Covid-19 Vaccine Revenue Market Share by Application (2021–2026)

Table 32. Global Covid-19 Vaccine Forecasted Market Size by Application (US$ Million), 2027–2032

Table 33. Global Covid-19 Vaccine Revenue Market Share by Application (2027–2032)

Table 34. North America Covid-19 Vaccine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. North America Covid-19 Vaccine Market Size by Country (US$ Million), 2021–2026

Table 36. North America Covid-19 Vaccine Market Size by Country (US$ Million), 2027–2032

Table 37. Europe Covid-19 Vaccine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 38. Europe Covid-19 Vaccine Market Size by Country (US$ Million), 2021–2026

Table 39. Europe Covid-19 Vaccine Market Size by Country (US$ Million), 2027–2032

Table 40. Asia-Pacific Covid-19 Vaccine Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 41. Asia-Pacific Covid-19 Vaccine Market Size by Region (US$ Million), 2021–2026

Table 42. Asia-Pacific Covid-19 Vaccine Market Size by Region (US$ Million), 2027–2032

Table 43. Latin America Covid-19 Vaccine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Latin America Covid-19 Vaccine Market Size by Country (US$ Million), 2021–2026

Table 45. Latin America Covid-19 Vaccine Market Size by Country (US$ Million), 2027–2032

Table 46. Middle East & Africa Covid-19 Vaccine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 47. Middle East & Africa Covid-19 Vaccine Market Size by Country (US$ Million), 2021–2026

Table 48. Middle East & Africa Covid-19 Vaccine Market Size by Country (US$ Million), 2027–2032

Table 49. Moderna Company Details

Table 50. Moderna Business Overview

Table 51. Moderna Covid-19 Vaccine Product

Table 52. Moderna Revenue in Covid-19 Vaccine Business (US$ Million), 2021–2026

Table 53. Moderna Recent Development

Table 54. CanSino Biologicals Company Details

Table 55. CanSino Biologicals Business Overview

Table 56. CanSino Biologicals Covid-19 Vaccine Product

Table 57. CanSino Biologicals Revenue in Covid-19 Vaccine Business (US$ Million), 2021–2026

Table 58. CanSino Biologicals Recent Development

Table 59. Inovio Pharmaceuticals Company Details

Table 60. Inovio Pharmaceuticals Business Overview

Table 61. Inovio Pharmaceuticals Covid-19 Vaccine Product

Table 62. Inovio Pharmaceuticals Revenue in Covid-19 Vaccine Business (US$ Million), 2021–2026

Table 63. Inovio Pharmaceuticals Recent Development

Table 64. Shenzhen Geno-Immune Medical Institute Company Details

Table 65. Shenzhen Geno-Immune Medical Institute Business Overview

Table 66. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product

Table 67. Shenzhen Geno-Immune Medical Institute Revenue in Covid-19 Vaccine Business (US$ Million), 2021–2026

Table 68. Shenzhen Geno-Immune Medical Institute Recent Development

Table 69. GlaxoSmithKine Company Details

Table 70. GlaxoSmithKine Business Overview

Table 71. GlaxoSmithKine Covid-19 Vaccine Product

Table 72. GlaxoSmithKine Revenue in Covid-19 Vaccine Business (US$ Million), 2021–2026

Table 73. GlaxoSmithKine Recent Development

Table 74. Pfizer Company Details

Table 75. Pfizer Business Overview

Table 76. Pfizer Covid-19 Vaccine Product

Table 77. Pfizer Revenue in Covid-19 Vaccine Business (US$ Million), 2021–2026

Table 78. Pfizer Recent Development

Table 79. Johnson＆Johnson Company Details

Table 80. Johnson＆Johnson Business Overview

Table 81. Johnson＆Johnson Covid-19 Vaccine Product

Table 82. Johnson＆Johnson Revenue in Covid-19 Vaccine Business (US$ Million), 2021–2026

Table 83. Johnson＆Johnson Recent Development

Table 84. Heat Biologics Company Details

Table 85. Heat Biologics Business Overview

Table 86. Heat Biologics Covid-19 Vaccine Product

Table 87. Heat Biologics Revenue in Covid-19 Vaccine Business (US$ Million), 2021–2026

Table 88. Heat Biologics Recent Development

Table 89. Sanofi Company Details

Table 90. Sanofi Business Overview

Table 91. Sanofi Covid-19 Vaccine Product

Table 92. Sanofi Revenue in Covid-19 Vaccine Business (US$ Million), 2021–2026

Table 93. Sanofi Recent Development

Table 94. Research Programs/Design for This Report

Table 95. Key Data Information from Secondary Sources

Table 96. Key Data Information from Primary Sources

Table 97. Authors List of This Report

List of Figures

Figure 1. Covid-19 Vaccine Picture

Figure 2. Global Covid-19 Vaccine Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Covid-19 Vaccine Market Share by Type: 2025 vs 2032

Figure 4. DNA Features

Figure 5. Non-replicating Viral Vector Features

Figure 6. Protein Subunit Features

Figure 7. RNA Features

Figure 8. Others Features

Figure 9. Global Covid-19 Vaccine Market Size by Application (US$ Million), 2021–2032

Figure 10. Global Covid-19 Vaccine Market Share by Application: 2025 vs 2032

Figure 11. Adults Case Studies

Figure 12. Children Case Studies

Figure 13. Covid-19 Vaccine Report Years Considered

Figure 14. Global Covid-19 Vaccine Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global Covid-19 Vaccine Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Covid-19 Vaccine Market Share by Region: 2025 vs 2032

Figure 17. Global Covid-19 Vaccine Market Share by Players in 2025

Figure 18. Global Covid-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Covid-19 Vaccine Revenue in 2025

Figure 20. North America Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America Covid-19 Vaccine Market Share by Country (2021–2032)

Figure 22. United States Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Covid-19 Vaccine Market Share by Country (2021–2032)

Figure 26. Germany Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Covid-19 Vaccine Market Share by Region (2021–2032)

Figure 34. China Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Covid-19 Vaccine Market Share by Country (2021–2032)

Figure 42. Mexico Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Covid-19 Vaccine Market Share by Country (2021–2032)

Figure 46. Israel Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE Covid-19 Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Moderna Revenue Growth Rate in Covid-19 Vaccine Business (2021–2026)

Figure 50. CanSino Biologicals Revenue Growth Rate in Covid-19 Vaccine Business (2021–2026)

Figure 51. Inovio Pharmaceuticals Revenue Growth Rate in Covid-19 Vaccine Business (2021–2026)

Figure 52. Shenzhen Geno-Immune Medical Institute Revenue Growth Rate in Covid-19 Vaccine Business (2021–2026)

Figure 53. GlaxoSmithKine Revenue Growth Rate in Covid-19 Vaccine Business (2021–2026)

Figure 54. Pfizer Revenue Growth Rate in Covid-19 Vaccine Business (2021–2026)

Figure 55. Johnson＆Johnson Revenue Growth Rate in Covid-19 Vaccine Business (2021–2026)

Figure 56. Heat Biologics Revenue Growth Rate in Covid-19 Vaccine Business (2021–2026)

Figure 57. Sanofi Revenue Growth Rate in Covid-19 Vaccine Business (2021–2026)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Approved COVID 19 Vaccines Market Research Report 2025

COVID 19 RNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Novel Coronavirus COVID 19 Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global COVID 19 Diagnostic Testing Market Insights Forecast to 2030

COVID 19 DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Covid 19 Vaccine Bottle Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global COVID 19 Home Testing Products Market Research Report 2024

COVID 19 Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral COVID 19 Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global COVID 19 Diagnostic Kits Market Research Report 2025

Coronavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global COVID 19 Liquid Mask Market Research Report 2024

Global COVID 19 Diagnosis Market Insights Forecast to 2030

Global COVID 19 Antigen Kit Market Research Report 2024

Global COVID 19 Medicine Market Research Report 2024

VPM1002 Tuberculosis BCG Based Vaccine for Prevent Covid 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vials for COVID 19 Vaccine Market Research Report 2024

Clinical Treatment for Covid 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Include COVID 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions